Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adrian Adams Insider Profile
4 Followers
Adrian Adams, Chief Executive Officer, Director at Aralez Pharmaceuticals, holds 11.17K shares in Talphera (Ticker: TLPH), holds 134.80K shares in Akebia Therapeutics (Ticker: AKBA), holds 20.00K shares in Impel Pharmaceuticals (Ticker: IMPLQ).
Adrian Adams Aralez Pharmaceuticals (ARLZQ)Chief Executive Officer, Director
Aralez Pharmaceuticals (ARLZQ)
Chief Executive Officer, Director
Ranked #80,363 out of 98,501 Corporate Insiders
Profitable Transactions
0 out of 5 Profitable Transactions
Average Return
-22.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Adrian Adams holds in companies
Most Profitable Insider Trade
The most profitable trade made by Adrian Adams
Adrian Adams's Trading History
Aralez Pharmaceuticals
May 12, 2017
―
Uninformative Buy
―
$7.14K
Akebia Therapeutics
Jun 08, 2023
Director
Uninformative Buy
―
$187.37K
Impel Pharmaceuticals
Aug 19, 2021
―
Informative Buy
279.66K
$300.00
Auxilium
Jan 30, 2015
―
Uninformative Sell
4.39M
―
Talphera
Dec 13, 2023
Director
Uninformative Buy
―
$11.61K
Neurocrine
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Adrian Adams's performance on stock
You May Also Like
Adrian Adams insider profile FAQ
What is the percentage of profitable transactions made by Adrian Adams?
The percentage of profitable transactions made by Adrian Adams is 0%.
What is the average return per transaction made by Adrian Adams?
The average return per transaction made by Adrian Adams is -22.10%.
What stocks does Adrian Adams hold?
Adrian Adams holds: ARLZQ, AKBA, IMPLQ, AUXL, TLPH, NBIX stocks.
What was Adrian Adams’s latest transaction?
Adrian Adams latest transaction was an Uninformative Buy of ―.
What was Adrian Adams's most profitable transaction?
Adrian Adams’s most profitable transaction was an Informative Sell of TLPH stock on June 15, 2020. The return on the trade was -4.50%.
What is Adrian Adams's role in Aralez Pharmaceuticals?
Adrian Adams's role in Aralez Pharmaceuticals is Chief Executive Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.